RBC Stock Recent News

PTC stock hit a nine-month high Monday after the European Commission decided against pulling its drug, Translarna, from the market. Translarna has a conditional approval in Europe to treat patients with a muscle-wasting disease known as Duchenne muscular dystrophy, or DMD. Twice — in September and January — the Committee for Medicinal Products for Human Use issued a negative opinion on the PTC Therapeutics (PTCT) drug. But following what PTC previously called "tremendous outcry from the patient and physician community," the European Commission has asked its committee to reexamine its opinion. And, so, "Translarna lives to fight another day," Leerink Partners analyst Joseph Schwartz said in a report to clients. It's rare for the European Commission to not adopt its committee's opinion, RBC Capital Markets analyst Brian Abrahams said in a client note. The news Monday increases the chances Translarna remains on the market in Europe and other jurisdictions, he said. But U.S. approval i

RBC Bearings' (RBC) fourth-quarter fiscal 2024 adjusted earnings increase 16% year over year, driven by higher revenues.

RBC Bearings Incorporated (NYSE:RBC ) Q4 2024 Earnings Conference Call May 17, 2024 11:00 AM ET Company Participants Josh Carroll - IR Michael Hartnett - Chairman, President & CEO Robert Sullivan - VP & CFO Conference Call Participants Kristine Liwag - Morgan Stanley Pete Skibitski - Alembic Global Steve Barger - KeyBanc Capital Markets Michael Ciarmoli - Truist Securities Vivek Srivastava - Goldman Sachs Jordan Lyonnais - Bank of America Operator Greetings, and welcome to RBC Bearings Fiscal 2024 Fourth Quarter Earnings Call. At this time, all participants are in a listen-only mode.

OXFORD, Conn.--(BUSINESS WIRE)--RBC Bearings Incorporated (NYSE: RBC, RBCP), a leading international manufacturer of highly engineered precision bearings, components and essential systems for the industrial, defense and aerospace industries, today reported results for the fourth quarter and full year fiscal 2024. Fourth Quarter Financial Highlights Fourth quarter net sales of $413.7 million increased 4.9% over last year, Aerospace/Defense up 16.8% and Industrial down 0.4%. Gross margin of 43.1%.

Leading global commerce company to present at the Barrington, RBC Capital Markets, and IDEAS conferences this quarter Leading global commerce company to present at the Barrington, RBC Capital Markets, and IDEAS conferences this quarter

The Zacks Manufacturing - General Industrial industry rides on growth in manufacturing activities for industrial products and easing supply-chain disruptions. IR, GTLS, AIT and RBC are some promising stocks in the industry.

RBC Bearings (RBC) is set to benefit from strong momentum in the Aerospace/Defense segment. However, weakness in the semiconductor market remains a concern.

Recovery in build rates from OEMs and stability in the aftermarket bode well for RBC Bearings (RBC). The company's measures to reward its shareholders are promising.

OXFORD, Conn.--(BUSINESS WIRE)--RBC Bearings Incorporated (NYSE: RBC, RBCP), a leading international manufacturer of highly engineered precision bearings, components and essential systems for the industrial, defense and aerospace industries, today announced that it will participate in the Alembic Global Advisors Investor Conference on February 28, 2024, in Deer Valley, Utah. Materials shared during the conference will be available online at: http://investor.rbcbearings.com. Vice President and C.

RBC Bearings' (RBC) third-quarter fiscal 2024 adjusted earnings increase 12.8% year over year, driven by higher revenues.